XOMA Royalty (XOMA) Depreciation & Amortization - Total (2024 - 2026)
XOMA Royalty (XOMA) reported Depreciation & Amortization - Total of $3000.0 for Q1 2026, little changed on a YoY basis from $3000.0 in Q1 2025, and little changed sequentially from $3000.0 in Q4 2025.
XOMA Royalty (XOMA) Depreciation & Amortization - Total (2024 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 3 years of Depreciation & Amortization - Total data on file, last reported at $3000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization - Total changed 0.0% year-over-year to $3000.0; the trailing twelve-month figure through Mar 2026 stood at $9000.0 (down 18.18% YoY), and the FY2025 full-year result was $11000.0, up 10.0% from the prior year.
- Depreciation & Amortization - Total was little changed at $3000.0 in Q1 2026, from $3000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $3000.0 in Q2 2024 to a low of $2000.0 in Q1 2024.
- A 3-year average of $2750.0 and a median of $3000.0 in 2024 frame the typical range for Depreciation & Amortization - Total.
- Peak annual rise in Depreciation & Amortization - Total reached 50.0% in 2025, while the deepest fall reached 0.0% in 2025.
- Tracing XOMA's Depreciation & Amortization - Total over 3 years: stood at $2000.0 in 2024, then jumped by 50.0% to $3000.0 in 2025, then changed by 0.0% to $3000.0 in 2026.
- Business Quant data shows XOMA's Depreciation & Amortization - Total at $3000.0 in Q1 2026, $3000.0 in Q4 2025, and $3000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 2,000.00 |